Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
Enteris Biopharma Doses First Woman in Phase 2a Clinical Trial August 28, 2017
Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, recently announced the first...Aptevo Therapeutics Highlights ADAPTIR™ Protein Therapeutic Platform June 12, 2017
Aptevo Therapeutics Inc. recently announced that aspects of its ADAPTIR protein therapeutic platform were showcased recently at the Americas Antibody...SPECIAL FEATURE - Wanted: New Excipients to Meet the Demands of a Challenging Industry June 1, 2017
Contributor Cindy H. Dubin recently spoke with some of the leading excipient innovators to find out what types of excipients they are developing, the advantages they offer to formulations, and where they see the industry focusing throughout the next few years.
EXECUTIVE INTERVIEW - Oasmia Pharmaceutical: Commercializing Technologies While Pursuing the US Market May 1, 2017
Julian Aleksov, Executive Chairman of Oasmia Pharmaceutical, discusses his company’s efforts to enter the US market, its strategy to increase commercial adoption, and why it believes its underlying drug delivery system technology is significant not only within the oncology sector, but the entire pharmaceutical industry.
GNT Biotech & Medicals Corporation to Begin Phase III Clinical Trial April 24, 2017
GNT Biotech & Medicals Co., Ltd. recently announced that the anticancer drug Chidamide (HBI-8000), an epigenetic regulator developed by Chipscreen...UroGen Pharma Announces Enrollment of First Patient in Phase III Clinical Trial April 10, 2017
UroGen Pharma Ltd. recently announced the first patient has been enrolled in the OLYMPUS trial, an open-label, single-arm pivotal Phase...ANTIMICROBIAL RESISTANCE - MGB: The Minor Groove Binder April 3, 2017
Dawn A. Firmin, MSc, PhD, explains how MGB has dedicated its focus to the development of a new class of small molecules, with specific antibacterial activity against susceptible and resistant bacteria.
ANTIMICROBIAL LIPIDS - Attenuating the Use of Medically Important Antimicrobial Drugs in Food-Producing Animals: What Role Can cGMP Lipids Play? April 3, 2017
Ryan Littich, PhD, highlights some of the most significant, pathogen-borne diseases relevant to food-producing animals and reviews the antimicrobial properties intrinsic to midchain triglyceride lipolysis products.
Aclaris Therapeutics Submits NDA for Seborrheic Keratosis March 6, 2017
Aclaris Therapeutics, Inc. recently announced it has submitted a New Drug Application (NDA) to the US FDA for A-101 40%...AAV VECTOR MANUFACTURING - Challenges & Opportunities in the Manufacturing of AAV Vectors Used in the Delivery of Gene Therapy Treatments February 28, 2017
Daniel C. Smith, PhD, indicates there remains a clear need for improved process productivities, and the need to develop manufacturing processes that can be applied to a wide number of AAV-based viral vector therapeutic candidates.
SPECIAL FEATURE - Bioavailability & Solubility: New Approaches to Enhance Drug Performance February 27, 2017
Contributor Cindy H. Dubin highlights many of the latest techniques to enhance bioavailability and solubility, how to determine the right technique for your compound, and how some companies are realizing faster time to market as a result.
Tetraphase Pharmaceuticals Doses First Patient in Phase III Trial January 23, 2017
Tetraphase Pharmaceuticals, Inc. recently announced dosing of the first patient in IGNITE3, the company’s Phase III clinical trial evaluating the...SPECIAL FEATURE - Analytical Testing: Market Drivers, Growing Demand & Client Needs January 17, 2017
Contributor Cindy H. Dubin spoke with several testing providers to find out what services they offer, trends they identify, and how they have specifically addressed clients’ needs throughout the past year.
Catalent to Develop Softgel Capsules for JOT's Leading Orphan Disease Candidates January 9, 2017
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health...Lonza to Acquire Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma & Consumer Healthcare Industries December 14, 2016
Lonza Group AG, KKR, and Capsugel S.A. recently announced they have entered into a definitive agreement under which Lonza will...FDA Accepts Genentech’s Biologics License Application November 11, 2016
Halozyme Therapeutics, Inc. recently announced that the US FDA has accepted Genentech's Biologics License Application for a subcutaneous formulation of...Daiichi Sankyo & Inspirion Delivery Sciences Announce Licensing Agreement October 29, 2016
Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC recently announced the companies have entered into a strategic collaboration agreement in...Capsugel Launches Vcaps for Enteric Protection & Delayed Release October 7, 2016
Capsugel recently announced the launch of its Vcaps® Enteric capsules, a new functional capsule technology that achieves enteric protection and...ADVANCED DELIVERY DEVICES - Sophisticated Connected Wearables: Boosting Biologics’ Compliance, Value & Patient Satisfaction October 3, 2016
Michael D. Hooven, MSME, says the new, most advanced wearable large-volume injectors available now for clinical trials and commercial application are designed to address the challenges of formulating biologics, delivery complexity, patient compliance, and cost.
SPECIAL FEATURE - Platform Technologies: Not Just for Big Pharma October 3, 2016
Contributor Cindy H. Dubin recently spoke with several companies that are debunking the theory that access to the latest technological platforms to aid efficient drug discovery and development is limited to Big Pharma, which can more easily justify the costs of creating and operating innovative platforms.
Company Profiles
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...CycloLab Cyclodextrin Research & Development Ltd.
CycloLab Cyclodextrin Research & Development Ltd. E: commerce@cyclolab.hu W: cyclolab.hu LinkedIn: https://www.linkedin.com/company/10040240 For more than 30 years, Cyclolab Ltd. has been involved in...
